HAX’s VC-Founder Industry Hard Tech Matchup is now accepting applications. Register today!
Back to news articles
Amid two clinical trials, Sana Health raises $5.8M for chronic pain treatment mask
Hannah DeTavis
The Sana device uses audio-visual technology to relieve chronic fibromyalgia pain
The Sana device uses audio-visual technology to relieve chronic fibromyalgia pain. Source: Sana Health

Sana Health (HAX 08), a Layfayette, Colorado-based startup, is gaining attention for its audio-visual masks built to treat chronic pain. As the company prepares to close out two clinical trials for treating fibromyalgia pain, Sana has raised $5.8M through a sale of preferred stock and convertible notes to 44 investors.

Sana’s total capital raised over its six rounds since 2017 is more than $13.63M, according to SEC filings.

One day prior to the most recent fundraiser, Sana announced that the FDA approved the Sana device, which uses audio waves to stimulate parts of the brain to relieve fibromyalgia pain, for sale as a “general wellness” device.

Sana is currently undergoing trials at both Duke University for fibromyalgia and Mount Sinai Health System in New York for broader neuropathy. A pilot study on 20 patients in Colorado indicated that the device was three times more efficient than the leading fibromyalgia medication, minus the side effects of the drug.

In an interview with BizWest, CEO Richard Hanbury said, “We have a solution in an area that is desperately needed.”